Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02178722 |
Title | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Incyte Corporation |
Indications |
renal pelvis transitional cell carcinoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma triple-receptor negative breast cancer clear cell renal cell carcinoma urethra transitional cell carcinoma Her2-receptor negative breast cancer prostate transitional cell carcinoma endometrial transitional cell carcinoma fallopian tube transitional cell carcinoma |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |